- Home
- ADT vs BHVN Comparison
ADT vs BHVN Comparison
Compare ADT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADT
- BHVN
- Stock Information
- Founded
- ADT 1874
- BHVN 2013
- Country
- ADT United States
- BHVN United States
- Employees
- ADT N/A
- BHVN N/A
- Industry
- ADT Diversified Commercial Services
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- ADT Consumer Discretionary
- BHVN Health Care
- Exchange
- ADT Nasdaq
- BHVN Nasdaq
- Market Cap
- ADT 6.4B
- BHVN 5.4B
- IPO Year
- ADT 2018
- BHVN 2017
- Fundamental
- Price
- ADT $7.49
- BHVN $44.39
- Analyst Decision
- ADT Hold
- BHVN Strong Buy
- Analyst Count
- ADT 3
- BHVN 13
- Target Price
- ADT $8.40
- BHVN $63.42
- AVG Volume (30 Days)
- ADT 10.5M
- BHVN 725.9K
- Earning Date
- ADT 10-24-2024
- BHVN 11-12-2024
- Dividend Yield
- ADT 2.94%
- BHVN N/A
- EPS Growth
- ADT 2041.84
- BHVN N/A
- EPS
- ADT 0.98
- BHVN N/A
- Revenue
- ADT $5,140,300,000.00
- BHVN N/A
- Revenue This Year
- ADT N/A
- BHVN N/A
- Revenue Next Year
- ADT $4.27
- BHVN $179.00
- P/E Ratio
- ADT $7.58
- BHVN N/A
- Revenue Growth
- ADT 7.14
- BHVN N/A
- 52 Week Low
- ADT $5.63
- BHVN $26.80
- 52 Week High
- ADT $8.25
- BHVN $62.21
- Technical
- Relative Strength Index (RSI)
- ADT 52.43
- BHVN 33.48
- Support Level
- ADT $7.57
- BHVN $51.80
- Resistance Level
- ADT $7.86
- BHVN $54.53
- Average True Range (ATR)
- ADT 0.17
- BHVN 2.42
- MACD
- ADT -0.00
- BHVN -0.92
- Stochastic Oscillator
- ADT 45.65
- BHVN 9.80
About ADT ADT Inc.
ADT Inc is a provider of monitored security, interactive home and business automation, and related monitoring services in the United States and Canada. It offers residential, commercial, and multi-site customers a comprehensive set of burglary, video, access control, fire and smoke alarm, and medical alert solutions. The company segments include Consumer and Small Business (CSB), Commercial, and Solar. It generates maximum revenue from the Commercial segment.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.